Medicine guide
ROMVIMZA 14 mg
As listed in the register: ROMVIMZA 14 mg, gélule
· gélule
- Prescription only
- Active substance
- Vimseltinib Dihydraté
- Made by
- DECIPHERA PHARMACEUTICALS (NETHERLANDS) (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | DECIPHERA PHARMACEUTICALS (NETHERLANDS) (PAYS-BAS) |
|---|---|
| Active substance | Vimseltinib Dihydraté |
| Form | gélule |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/25/1968 |
| Name in the register | ROMVIMZA 14 mg, gélule |
| Packs | plaquette(s) thermoformée(s) OPA : polyamide orienté aluminium PVC avec fermeture de sécurité enfant de 8 gélule(s) |
| CIS | 68364291 |
| CIP13 | 3400930326992 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.